MiR-21 is Overexpressed in Response to High Glucose and Protects Endothelial Cells from Apoptosis

Abstract

Diabetes was an increasing public health problem nowadays. Accumulating evidences had shed a light on the involvement of endothelial cell dysfunction in the pathogenesis of diabetes-associated vascular diseases. MiR-21, a multiple-functional miRNA, was evidenced to be involved in endothelial dysfunction, however, the underlying molecular mechanisms were still unknown. In current study, we investigated the intrinsic link between miR-21 and high glucose-induced endothelial dysfunction. We demonstrated that expression of miR-21 was elevated in circulating endothelial progenitor cells from diabetes patients. Further, inhibition of miR-21 markedly enhanced high glucose-induced endothelial cytotoxicity. Furthermore, proteomic profiling was applied to analyze the downstream effectors involved in miR-21-meidated protection of endothelial cells. A total of 31 proteins were positively identified, including Annexin A2, S100A4, SOD2, Thioredoxin and DAXX. Altered expression of these proteins was validated by immunoblot. Finally, mechanistic study showed that miR-21 protected endothelial cell against high glucose-induced endothelial cytotoxicity probably by inhibiting the expression of DAXX. Our findings were considered as a significant step toward a better understanding of diabetes-associated vascular diseases.

Key words

miR-21 - diabetes - endothelial dysfunction - high glucose - apoptosis

• References

• 1 Varughese G, Lip G. Hypertension in patients with type-II diabetes: relation to urinary albumin excretion, endothelial function and inflammation. Journal of human hypertension 2005; 19: 421-424
• 2 Alexander H, Lockwood LP, Harris MA et al. Risk factors for cardiovascular disease and diabetes in two groups of Hispanic Americans with differing dietary habits. Journal of the American College of Nutrition 1999; 18: 127-136
• 3 Pereira A, Paulo M, Araújo A et al. Nitric oxide synthesis and biological functions of nitric oxide released from ruthenium compounds. Brazilian Journal of Medical and Biological Research 2011; 44: 947-957
• 4 Horvath B, Hegedus D, Szapary L et al. Measurement of von Willebrand factor as the marker of endothelial dysfunction in vascular diseases. Experimental & Clinical Cardiology 2004; 9: 31
• 5 Okon EB, Szado T, Laher I et al. Augmented contractile response of vascular smooth muscle in a diabetic mouse model. Journal of vascular research 2003; 40: 520-530
• 6 Zhang Y, Shi H, Sun G et al. High glucose induces dysfunction and apoptosis in endothelial cells: is the effect of high glucose persistence more important than concentration?. Experimental and Clinical Endocrinology & Diabetes 2010; 119: 225-233
• 7 van den Oever IA, Raterman HG, Nurmohamed MT et al. Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus. Mediators of inflammation 2010; 2010
• 8 Mukhopadhyay P, Pacher P, Das DK. MicroRNA signatures of resveratrol in the ischemic heart. Annals of the New York Academy of Sciences 2011; 1215: 109-116
• 9 Urbich C, Kuehbacher A, Dimmeler S. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovascular research 2008; 79: 581-588
• 10 Li S, Liang Z, Xu L et al. MicroRNA-21: a ubiquitously expressed pro-survival factor in cancer and other diseases. Molecular and cellular biochemistry 2012; 360: 147-158
• 11 Li T, Li D, Sha J et al. MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Biochemical and biophysical research communications 2009; 383: 280-285
• 12 Weber M, Baker MB, Moore JP et al. MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity. Biochemical and biophysical research communications 2010; 393: 643-648
• 13 Zhou J, Wang KC, Wu W et al. MicroRNA-21 targets peroxisome proliferators-activated receptor-α in an autoregulatory loop to modulate flow-induced endothelial inflammation. Proceedings of the National Academy of Sciences 2011; 108: 10355-10360
• 14 Sabatel C, Malvaux L, Bovy N et al. MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells. PLoS One 2011; 6: e16979
• 15 Zhou J, Wang K-C, Wu W et al. MicroRNA-21 targets peroxisome proliferators-activated receptor-α in an autoregulatory loop to modulate flow-induced endothelial inflammation. Proceedings of the National Academy of Sciences 2011; 108: 10355-10360
• 16 Li AF, Roy S. High glucose – induced downregulation of connexin 43 expression promotes apoptosis in microvascular endothelial cells. Investigative ophthalmology & visual science 2009; 50: 1400-1407
• 17 Li Y, Wu H, Khardori R et al. Insulin-like growth factor-1 receptor activation prevents high glucose-induced mitochondrial dysfunction, cytochrome-c release and apoptosis. Biochemical and biophysical research communications 2009; 384: 259-264
• 18 Piconi L, Corgnali M, Da Ros R et al. The protective effect of rosuvastatin in human umbilical endothelial cells exposed to constant or intermittent high glucose. Journal of diabetes and its complications 2008; 22: 38
• 19 Yu T, Sheu SS, Robotham JL et al. Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen species. Cardiovascular research 2008; 79: 341-351
• 20 Perlman R, Schiemann WP, Brooks MW et al. TGF-β-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nature cell biology 2001; 3: 708-714
• 21 Papagiannakopoulos T, Shapiro A, Kosik KS. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Research 2008; 68: 8164-8172
• 22 Hartge MM, Unger T, Kintscher U. The endothelium and vascular inflammation in diabetes. Diabetes and Vascular Disease Research 2007; 4: 84-88
• 23 Ling H-y, Hu B, Hu X-b et al. MiRNA-21 Reverses High Glucose and High Insulin Induced Insulin Resistance in 3T3-L1 Adipocytes through Targeting Phosphatase and Tensin Homologue. Experimental and Clinical Endocrinology & Diabetes 2012; 120: 553-559
• 24 Thum T, Gross C, Fiedler J et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008; 456: 980-984
• 25 Haider KH, Idris NM, Kim HW et al. MicroRNA-21 is a key determinant in IL-11/Stat3 anti-apoptotic signalling pathway in preconditioning of skeletal myoblasts. Cardiovascular research 2010; 88: 168-178
• 26 Yang X, Khosravi-Far R, Chang HY et al. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 1997; 89: 1067
• 27 Salomoni P, Khelifi AF. Daxx: death or survival protein?. Trends in cell biology 2006; 16: 97-104